Event
Brenna Jenny and Sean Griffin Speaking on Washington Legal Foundation Webinar
Wednesday, August 28, 2024
Event Details
DateWednesday, August 28, 2024
Sidley partners Brenna Jenny and Sean Griffin will be speaking on a webinar hosted by the Washington Legal Foundation titled, “High Court’s Healthcare Impact: Fines, FDA Authority, and More Post-Loper Bright and Jarkesy” on August 28, 2024 at 1:00 p.m. - 2:00 p.m. ET.
The Supreme Court’s June 2024 pronouncements on judicial deference and the Seventh Amendment created new opportunities and risks for businesses regulated by HHS, including FDA and CMS. Our speakers will leverage directly relevant private and public client representation to assess the opportunities, which include challenging HHS regulatory overreach and seeking adjudication of civil monetary penalties in courts rather than in-house agency processes, and the risks, such as less predictability in drug approval and a shift to equitable forms of remedies.
The Supreme Court’s June 2024 pronouncements on judicial deference and the Seventh Amendment created new opportunities and risks for businesses regulated by HHS, including FDA and CMS. Our speakers will leverage directly relevant private and public client representation to assess the opportunities, which include challenging HHS regulatory overreach and seeking adjudication of civil monetary penalties in courts rather than in-house agency processes, and the risks, such as less predictability in drug approval and a shift to equitable forms of remedies.
Offices
Capabilities
Suggested News & Insights
Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026Sidley Represents Underwriters in Connection With Pharvaris’ US$115 Million Underwritten Offering of Ordinary SharesMay 8, 2026Sidley Represents Archimed in US$1.1 Billion Acquisition of Esperion TherapeuticsMay 1, 2026Most-Favored-Nation Drug Pricing Policy: Executive Actions, Manufacturer Agreements, and Growing Congressional ScrutinyApril 22, 2026Sidley Represents Opus Genetics in US$155 Million Financing With Oberland CapitalApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
